相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。2013 Alzheimer's disease facts and figures Alzheimer's Association
William Thies et al.
ALZHEIMERS & DEMENTIA (2013)
Immunotherapy in Alzheimer's Disease: Do We Have All the Pieces of the Puzzle?
Marie Sarazin et al.
BIOLOGICAL PSYCHIATRY (2013)
Effect of Complement CR1 on Brain Amyloid Burden During Aging and Its Modification by APOE Genotype
Madhav Thambisetty et al.
BIOLOGICAL PSYCHIATRY (2013)
CR1 and the Vanishing Amyloid Hypothesis of Alzheimer's Disease
Sam Gandy et al.
BIOLOGICAL PSYCHIATRY (2013)
Safety and Pharmacology of Ponezumab (PF-04360365) After a Single 10-Minute Intravenous Infusion in Subjects With Mild to Moderate Alzheimer Disease
Aaron H. Burstein et al.
CLINICAL NEUROPHARMACOLOGY (2013)
Safety and Pharmacology of a Single Intravenous Dose of Ponezumab in Subjects With Mild-to-Moderate Alzheimer Disease: A Phase I, Randomized, Placebo-Controlled, Double-Blind, Dose-Escalation Study
Jaren W. Landen et al.
CLINICAL NEUROPHARMACOLOGY (2013)
Immunotherapy for Targeting Tau Pathology in Alzheimer's Disease and Tauopathies
Hanna Rosenmann
CURRENT ALZHEIMER RESEARCH (2013)
Repeated immunization of mice with phosphorylated-tau peptides causes neuroinflammation
Lea Rozenstein-Tsalkovich et al.
EXPERIMENTAL NEUROLOGY (2013)
Bapineuzumab and solanezumab for Alzheimer's disease: is the 'amyloid cascade hypothesis' still alive?
Haythum O. Tayeb et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2013)
Clinical trials of amyloid-based immunotherapy for Alzheimer's disease: end of beginning or beginning of end?
Yun Li et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2013)
Intravenous immunoglobulin and Alzheimer's disease: what now?
David A. Loeffler
JOURNAL OF NEUROINFLAMMATION (2013)
Therapeutic strategies for tau mediated neurodegeneration
Yasumasa Yoshiyama et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
Immunogenicity, Efficacy, Safety, and Mechanism of Action of Epitope Vaccine (Lu AF20513) for Alzheimer's Disease: Prelude to a Clinical Trial
Hayk Davtyan et al.
JOURNAL OF NEUROSCIENCE (2013)
Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial
Richard Dodel et al.
LANCET NEUROLOGY (2013)
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
Victor L. Villemagne et al.
LANCET NEUROLOGY (2013)
Immunotherapy for Alzheimer's disease: hoops and hurdles
Cynthia A. Lemere
MOLECULAR NEURODEGENERATION (2013)
Active vaccination with ankyrin G reduces β-amyloid pathology in APP transgenic mice
A. C. Santuccione et al.
MOLECULAR PSYCHIATRY (2013)
Immunization targeting a minor plaque constituent clears β-amyloid and rescues behavioral deficits in an Alzheimer's disease mouse model
Jose Morales-Corraliza et al.
NEUROBIOLOGY OF AGING (2013)
Alzheimer's Disease Risk Gene CD33 Inhibits Microglial Uptake of Amyloid Beta
Ana Griciuc et al.
NEURON (2013)
Variant TREM2 as Risk Factor for Alzheimer's Disease
Harald Neumann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Development of a New DNA Vaccine for Alzheimer Disease Targeting a Wide Range of Aβ Species and Amyloidogenic Peptides
Yoh Matsumoto et al.
PLOS ONE (2013)
Passive anti-amyloid immunotherapy in Alzheimer's disease: What are the most promising targets?
Jens Moreth et al.
IMMUNITY & AGEING (2013)
Safety and biomarker effects of Solanezumab in patients with Alzheimer's disease
Martin Farlow et al.
ALZHEIMERS & DEMENTIA (2012)
Mechanism of Amyloid Removal in Patients With Alzheimer Disease Treated With Gantenerumab
Susanne Ostrowitzki et al.
ARCHIVES OF NEUROLOGY (2012)
Effect of Immunotherapy With Bapineuzumab on Cerebrospinal Fluid Biomarker Levels in Patients With Mild to Moderate Alzheimer Disease
Kaj Blennow et al.
ARCHIVES OF NEUROLOGY (2012)
Nuclear signalling by membrane protein intracellular domains: The AICD enigma
Caroline Beckett et al.
CELLULAR SIGNALLING (2012)
AICD Nuclear Signaling and Its Possible Contribution to Alzheimer's Disease
Uwe Konietzko
CURRENT ALZHEIMER RESEARCH (2012)
Targeting Phospho-Ser422 by Active Tau Immunotherapy in the THY-Tau22 Mouse Model: A Suitable Therapeutic Approach
Laetitia Troquier et al.
CURRENT ALZHEIMER RESEARCH (2012)
Gantenerumab for the treatment of Alzheimer's disease
Julien Delrieu et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2012)
Solanezumab for the treatment of mild-to-moderate Alzheimer's disease
Bruno P. Imbimbo et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2012)
New and emerging treatments for Alzheimer's disease
Anne Corbett et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2012)
Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies
Francesco Panza et al.
IMMUNOTHERAPY (2012)
Anti-apoE immunotherapy inhibits amyloid accumulation in a transgenic mouse model of Aβ amyloidosis
Jungsu Kim et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
The physiology of the beta-amyloid precursor protein intracellular domain AICD
Raphaelle Pardossi-Piquard et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Intranasal inoculation with an adenovirus vaccine encoding ten repeats of Aβ3-10 reduces AD-like pathology and cognitive impairment in Tg-APPswe/PSEN1dE9 mice
Yu Li et al.
JOURNAL OF NEUROIMMUNOLOGY (2012)
An Effector-Reduced Anti-β-Amyloid (Aβ) Antibody with Unique Aβ Binding Properties Promotes Neuroprotection and Glial Engulfment of Aβ
Oskar Adolfsson et al.
JOURNAL OF NEUROSCIENCE (2012)
Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study
Bengt Winblad et al.
LANCET NEUROLOGY (2012)
Genentech's Alzheimer's antibody trial to study disease prevention
Ken Garber
NATURE BIOTECHNOLOGY (2012)
Passive Immunization against Pyroglutamate-3 Amyloid-β Reduces Plaque Burden in Alzheimer-Like Transgenic Mice: A Pilot Study
Jeffrey L. Frost et al.
NEURODEGENERATIVE DISEASES (2012)
A Plaque-Specific Antibody Clears Existing β-amyloid Plaques in Alzheimer's Disease Mice
Ronald B. DeMattos et al.
NEURON (2012)
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
Randall J. Bateman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Stopping Alzheimer's Before It Starts
Greg Miller
SCIENCE (2012)
Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer's Association Research Roundtable Workgroup
Reisa A. Sperling et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Marilyn S. Albert et al.
ALZHEIMERS & DEMENTIA (2011)
Anti-β-Amyloid Immunotherapy for Alzheimer's Disease: Focus on Bapineuzumab
Francesco Panza et al.
CURRENT ALZHEIMER RESEARCH (2011)
Antibody-based therapy in Alzheimer's disease
Refik Pul et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2011)
Passive Immunization with Anti-Tau Antibodies in Two Transgenic Models REDUCTION OF TAU PATHOLOGY AND DELAY OF DISEASE PROGRESSION
Xiyun Chai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain
Allal Boutajangout et al.
JOURNAL OF NEUROCHEMISTRY (2011)
The Second-Generation Active Aβ Immunotherapy CAD106 Reduces Amyloid Accumulation in APP Transgenic Mice While Minimizing Potential Side Effects
Christoph Wiessner et al.
JOURNAL OF NEUROSCIENCE (2011)
Alzheimer's disease: clinical trials and drug development (vol 9, pg 702, 2010)
F. Mangialasche et al.
LANCET NEUROLOGY (2011)
Tau-Targeted Immunization Impedes Progression of Neurofibrillary Histopathology in Aged P301L Tau Transgenic Mice
Mian Bi et al.
PLOS ONE (2011)
Effect of rice-expressed amyloid β in the Tg2576 Alzheimer's disease transgenic mouse model
Jun Nojima et al.
VACCINE (2011)
The presence of sodium dodecyl sulphate-stable Aβ dimers is strongly associated with Alzheimer-type dementia
Jessica M. Mc Donald et al.
BRAIN (2010)
Safety and Changes in Plasma and Cerebrospinal Fluid Amyloid beta After a Single Administration of an Amyloid beta Monoclonal Antibody in Subjects With Alzheimer Disease
Eric R. Siemers et al.
CLINICAL NEUROPHARMACOLOGY (2010)
TAU Aggregation is a Therapeutic Target for Alzheimer's Disease
A. Takashima
CURRENT ALZHEIMER RESEARCH (2010)
Efficacy and safety of immunization with phosphorylated tau against neurofibrillary tangles in mice
Moran Boimel et al.
EXPERIMENTAL NEUROLOGY (2010)
The Transcriptionally Active Amyloid Precursor Protein (APP) Intracellular Domain Is Preferentially Produced from the 695 Isoform of APP in a β-Secretase-dependent Pathway
Nikolai D. Belyaev et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Human intravenous immunoglobulin provides protection against Aβ toxicity by multiple mechanisms in a mouse model of Alzheimer's disease
Johanna Magga et al.
JOURNAL OF NEUROINFLAMMATION (2010)
Immunotherapy Targeting Pathological Tau Prevents Cognitive Decline in a New Tangle Mouse Model
Allal Boutajangout et al.
JOURNAL OF NEUROSCIENCE (2010)
Revising the definition of Alzheimer's disease: a new lexicon
Bruno Dubois et al.
LANCET NEUROLOGY (2010)
11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
Juha O. Rinne et al.
LANCET NEUROLOGY (2010)
Can Alzheimer disease be prevented by amyloid-β immunotherapy?
Cynthia A. Lemere et al.
NATURE REVIEWS NEUROLOGY (2010)
APP Intracellular Domain Impairs Adult Neurogenesis in Transgenic Mice by Inducing Neuroinflammation
Kaushik Ghosal et al.
PLOS ONE (2010)
beta-Amyloid precursor protein metabolism: focus on the functions and degradation of its intracellular domain
Erica Buoso et al.
PHARMACOLOGICAL RESEARCH (2010)
Decreased Clearance of CNS β-Amyloid in Alzheimer's Disease
Kwasi G. Mawuenyega et al.
SCIENCE (2010)
Alzheimer's disease: clinical trials and drug development
Francesca Mangialasche et al.
LANCET NEUROLOGY (2010)
Mechanisms of tau-induced neurodegeneration
Khalid Iqbal et al.
ACTA NEUROPATHOLOGICA (2009)
Tau vaccine: Active immunization with misfolded tau protein attenuates tau pathology in the transgenic rat model of tauopathy
Michal Novak
Alzheimers & Dementia (2009)
Long-Term Follow-Up of Patients Immunized with AN1792: Reduced Functional Decline in Antibody Responders
Bruno Vellas et al.
CURRENT ALZHEIMER RESEARCH (2009)
Disease-Modifying Approach to the Treatment of Alzheimer's Disease From alpha-Secretase Activators to gamma-Secretase Inhibitors and Modulators
Francesco Panza et al.
DRUGS & AGING (2009)
Anti-Amyloid-beta Immunotherapy in Alzheimer's Disease: ACC-001 Clinical Trials Are Ongoing
J. Michael Ryan et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
Nuclear signaling by the APP intracellular domain occurs predominantly through the amyloidogenic processing pathway
Zoe V. Goodger et al.
JOURNAL OF CELL SCIENCE (2009)
Vaccination with Aβ-Displaying Virus-Like Particles Reduces Soluble and Insoluble Cerebral Aβ and Lowers Plaque Burden in APP Transgenic Mice
Patricia Bach et al.
JOURNAL OF IMMUNOLOGY (2009)
Aβ Immunotherapy: Intracerebral Sequestration of Aβ by an Anti-Aβ Monoclonal Antibody 266 with High Affinity to Soluble Aβ
Kaoru Yamada et al.
JOURNAL OF NEUROSCIENCE (2009)
DEVELOPMENT OF AFFITOPE VACCINES FOR ALZHEIMER'S DISEASE (AD) - FROM CONCEPT TO CLINICAL TESTING
A. Schneeberger et al.
JOURNAL OF NUTRITION HEALTH & AGING (2009)
Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies
Kurt R. Brunden et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
S. Salloway et al.
NEUROLOGY (2009)
Oligomeric amyloid β associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques
Robert M. Koffie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Alzheimer's disease-like pathological features in transgenic mice expressing the APP intracellular domain
Kaushik Ghosal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
DNA epitope vaccine containing complement component C3d enhances anti-amyloid-β antibody production and polarizes the immune response towards a Th2 phenotype
Nina Movsesyan et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
Long-term effects of Aβ42 immunisation in Alzheimer's disease:: follow-up of a randomised, placebo-controlled phase I trial
Clive Holmes et al.
LANCET (2008)
Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
Ganesh M. Shankar et al.
NATURE MEDICINE (2008)
Antibody capture of soluble A beta does not reduce cortical A beta amyloidosis in the PDAPP mouse
Peter Seubert et al.
NEURODEGENERATIVE DISEASES (2008)
Reducing AD-Like Pathology in 3xTg-AD Mouse Model by DNA Epitope Vaccine - A Novel Immunotherapeutic Strategy
Nina Movsesyan et al.
PLOS ONE (2008)
The amyloid precursor protein intracellular domain (AICD) as modulator of gene expression, apoptosis, and cytoskeletal dynamics -: Relevance for Alzheimer's disease
Thorsten Mueller et al.
PROGRESS IN NEUROBIOLOGY (2008)
Alzheimer's disease peptide epitope vaccine reduces insoluble but not soluble/oligomeric Aβ species in amyloid precursor protein transgenic mice
Irina Petrushina et al.
JOURNAL OF NEUROSCIENCE (2007)
Immunotherapy targeting pathological tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements
Ayodeji A. Asuni et al.
JOURNAL OF NEUROSCIENCE (2007)
Research criteria for the diagnosis of Alzheimers disease: revising the NINCDS-ADRDA criteria
Bruno Dubois et al.
LANCET NEUROLOGY (2007)
Oral vaccination with a viral vector containing Aβ cDNA attenuates age-related Aβ accumulation and memory deficits without causing inflammation in a mouse Alzheimer model
Akihiro Mouri et al.
FASEB JOURNAL (2007)
Absence of β-amyloid deposits after immunization in Alzheimer disease with Lewy body dementia
Stephanie Bombois et al.
ARCHIVES OF NEUROLOGY (2007)
Soluble protein oligomers in neurodegeneration:: lessons from the Alzheimer's amyloid β-peptide
Christian Haass et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Monoclonal antibodies that target pathological assemblies of A beta
Mary P. Lambert et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Tauopathy-like abnormalities and neurologic deficits in mice immunized with neuronal tau protein
Hanna Rosenmann et al.
ARCHIVES OF NEUROLOGY (2006)
Alzheimer's disease and the aging brain
Robert D. Terry
JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY (2006)
Nonviral Aβ DNA vaccine therapy against Alzheimer's disease:: Long-term effects and safety
Yoshio Okura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
A specific amyloid-β protein assembly in the brain impairs memory
S Lesné et al.
NATURE (2006)
Targeting amyloid-β peptide (Aβ) oligomers by passive immunization with a conformation-selective monoclonal antibody improves learning and memory in Aβ precursor protein (APP) transgenic mice
EB Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
HSV amplicon-mediated Aβ vaccination in Tg2576 mice:: differential antigen-specific immune responses
WJ Bowers et al.
NEUROBIOLOGY OF AGING (2005)
Mechanisms of A beta Plaque Clearance following Passive A beta Immunization
Dave Morgan
NEURODEGENERATIVE DISEASES (2005)
Prototype Alzheimer's disease vaccine using the immunodominant B cell epitope from β-amyloid and promiscuous T cell epitope pan HLA DR-binding peptide
MG Agadjanyan et al.
JOURNAL OF IMMUNOLOGY (2005)
Evaluation of the safety and immunogenicity of synthetic Aβ42 (AN1792) in patients with AD
AJ Bayer et al.
NEUROLOGY (2005)
Aβ vaccination effects on plaque pathology in the absence of encephalitis in Alzheimer disease
E Masliah et al.
NEUROLOGY (2005)
Aβ immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome
S Oddo et al.
NEURON (2004)
Gene vaccination to bias the immune response to amyloid-β peptide as therapy for Alzheimer disease
BX Qu et al.
ARCHIVES OF NEUROLOGY (2004)
Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease
I Ferrer et al.
BRAIN PATHOLOGY (2004)
Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization
JM Orgogozo et al.
NEUROLOGY (2003)
Reduction of β-amyloid plaques in brain of transgenic mouse model of Alzheimer's disease by EFRH-phage immunization
D Frenkel et al.
VACCINE (2003)
Neuropathology of cognitively normal elderly
DS Knopman et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2003)
Interactions of amyloidogenic proteins
BI Giasson et al.
NEUROMOLECULAR MEDICINE (2003)
Amyloid-β immunotherapy for Alzheimer's disease:: the end of the beginning
D Schenk
NATURE REVIEWS NEUROSCIENCE (2002)
The γ secretase-generated carboxyl-terminal domain of the amyloid precursor protein induces apoptosis via Tip60 in H4 cells
A Kinoshita et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Direct visualization of the gamma secretase-generated carboxyl-terminal domain of the amyloid precursor protein: association with Fe65 and translocation to the nucleus
A Kinoshita et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Brain to plasma amyloid-β efflux:: a measure of brain amyloid burden in a mouse model of Alzheimer's disease
RB DeMattos et al.
SCIENCE (2002)
The intracellular domain of the β-amyloid precursor protein is stabilized by Fe65 and translocates to the nucleus in a Notch-like manner
WT Kimberly et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The cell biology of Alzheimer's disease: uncovering the secrets of secretases
J Walter et al.
CURRENT OPINION IN NEUROBIOLOGY (2001)
Formation of neurofibrillary tangles in P301L tau transgenic mice induced by Aβ42 fibrils
J Götz et al.
SCIENCE (2001)
Immunization with a nontoxic/nonfibrillar amyloid-β homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice
EM Sigurdsson et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease
RB DeMattos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
F Bard et al.
NATURE MEDICINE (2000)
分享论文
